Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Predictors of kidney-related outcomes in chronic heart failure patients with concomitant type 2 diabetes mellitus treated with dapagliflozin

Event: Heart Failure 2024

Topic: Biomarkers

Session: ePosters in chronic heart failure - diagnostic methods

Access
Like
Thumbnail

Low levels of irisin predicted worsening kidney function in dapagliflozin-treated patients with chronic heart failure and concomitant type 2 diabetes mellitus

Event: Heart Failure 2024

Topic: Biomarkers

Session: Chronic heart failure - biomarkers 3

Access
Like
Thumbnail

Circulating levels of erythrocytes-derived vesicles related to poor glycaemia control in heart failure patients with type 2 diabetes mellitus

Event: Heart Failure 2024

Topic: Biomarkers

Session: Chronic heart failure - biomarkers 2

Access
Like
Thumbnail

Predictors of worsening kidney function and their relation to SGLT2 inhibitor dapagliflozin administration in type 2 diabetes mellitus patients with chronic heart failure

Event: ESC Preventive Cardiology 2024

Topic: Biomarkers

Session: Managing risk in the cardio-renal continuum

Access
Like
Thumbnail

Circulating Levels of erythrocytes-derived vesicles are associated with glucose control in type 2 diabetes mellitus patients with atrial fibrillation

Event: ESC Preventive Cardiology 2024

Topic: Diagnostic Methods

Session: Understanding cardiovascular risk development: novel mechanisms (1)

Access
Like
Thumbnail

Low serum irisin levels predicted newly atrial fibrillation in patients with any phenotypes of chronic heart failure

Event: EHRA 2024

Topic: Clinical

Session: Congenital

Access
Like
Thumbnail

Circulating levels of erythrocytes-derived vesicles related to poor glycaemia control in type 2 diabetes mellitus patients with atrial fibrillation

Event: EHRA 2024

Topic: Arrhythmias

Session: Miscellaneous 2

Access
Like
Thumbnail

Low irisin levels predict acutely decompensated heart failure in type 2 diabetes mellitus patients

Event: ESC Acute CardioVascular Care 2024

Topic: Biomarkers

Session: Acute heart failure

Access
Like
Thumbnail

The effect of sglt-2 inhibitor dapagliflozin on adropin serum levels in patients with chronic heart failure and concomitant type 2 diabetes mellitus

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: More insights into SGLT2i in heart failure

Access
Like
Thumbnail

Altered myokine profile and glycemic control in type 2 diabetes mellitus patients with heart failure

Event: Heart Failure 2023

Topic: Biomarkers

Session: Chronic heart Failure - biomarkers 2

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources